Patent ID: 8442842
Filing Date: 2013-05-14
Classification: G06Q,G16H

Abstract:
1. A pharmaceutical clearinghouse method used for institutional patient assistance programs (PAPs), the method comprising: providing a clearinghouse computer system having a processor coupled to a data storage device and a network connection to enable communication with external computer systems over at least one network; and using the clearinghouse system processor and data storage device: wherein the requested drug may or may not be manufactured by the pharmaceutical providers, wherein each pharmaceutical provider in the network of pharmaceutical providers funds all patients that are prescribed the pharmaceutical provider's brand up to a predetermined limit, wherein each of the pharmaceutical providers also contributes an allocated share of cash funds to cover all other patients requesting drugs provided by non-participating pharmaceutical providers, wherein the burden of supporting a brand of drugs manufactured by non-participating pharmaceutical providers is shared by the participating pharmaceutical providers in a manner proportional to the benefit derived by the pharmaceutical provider in the form of its own drug subsidies through the clearinghouse relative to the other pharmaceutical participants, wherein the clearinghouse system does not electronically reveal an identity of the FNA agent to the plurality of pharmaceutical providers or an identity of the plurality of pharmaceutical providers to the FNA agent, wherein there is no data exchange between the clearinghouse and the pharmaceutical provider or between the foundations and pharmaceutical providers that allows pharmaceutical subsidy providers to correlate their donations to the number of prescriptions subsidized by a charity.